Product logins

Find logins to all Clarivate products below.


Deep Venous Disease Treatment Devices | Market Insights | Global | 2021

The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments, along with the evolving PV stent market. This market will grow moderately across all geographies covered through 2029, driven by increasing adoption of endovascular treatment modalities in the treatment of deep venous disease and introduction of new and innovative technologies. However, the market will be impacted in the short term by the COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the global market for deep venous disease treatment devices across a 10-year period.

Related Medtech Insights Reports

Report
Pulmonology Devices | Market Insights | US | 2021
​In 2020, the US pulmonology device market will be moderately impacted by the COVID-19 pandemic but will nevertheless grow over the forecast period, fueled by bronchoscopy procedure volume…
Report
Neurovascular Devices | Market Insights | US | 2021
The COVID-19 pandemic will have a modest impact on the US market for neurovascular devices in the short term. Once the impact subsides, adoption of innovative devices as well as the ongoing…
Report
Interventional Oncology Devices | Market Insights | US | 2021
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow modestly through 2029. This will be driven largely by the…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | US | 2021
Following the initial impact of the COVID-19 pandemic, the US market for TEO devices will expand at a moderate rate. Market growth will be driven by continual product innovations and the…
Report
Biosurgical Agents | Market Insights | Latin America | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by …